Recap of Psychedelic Science 2017: Interview with Joe Mattia and Lana Baumgartner

Last week saw the end of Psychedelic Science 2017, a six-day global conference hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS) that featured some of the brightest minds in today’s psychedelic movement. In attendance at this historic event were Joe Mattia and Lana Baumgartner, founders of PsychedelicTimes.com and eager participants in the psychedelic advocacy […]

Continue Reading

Are Psychedelics Medicine? Understanding the Safety & Therapeutic Value of Psychedelics

For anyone skeptical of the mental health benefits of psychedelics, hearing them referred to as “medicine” is sure to cause eye-rolling. Since the late 1960’s, psychedelics have been portrayed as dangerous, frivolous, and inherently anti-establishment. Any self-respecting adult would surely avoid taking psychedelics for fear of going crazy or jumping off a building. From the […]

Continue Reading

Why Decriminalization Is the Harm Reduction Tactic We Need to Treat Society’s Drug Problem

In 1977, Kenya imposed a nationwide hunting ban in response to illegal poaching that was depleting the country’s elephant populations. Zimbabwe was facing a similar problem, but instead of a ban, they did nothing. The next decade showed a contradictory lesson in economics and sociology: Kenya’s elephant population continued to drop dramatically, almost 90%, while […]

Continue Reading

How Donald Trump’s Cabinet Could Affect Executive Policies on Psychedelics

In the wake of the 2016 Presidential election, many people are wondering how the country will change under the leadership of President-elect Trump. Personally, I have been overjoyed at the increased freedom under the Obama Administration. Less than a year after Washington State legalized recreational cannabis, Obama’s justice department issued the Cole Memorandum, which expressed […]

Continue Reading